Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shohei Udagawa
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research,
Kohsei Chuo General Hospital
ORCID:
0009-0005-2225-7346
Observed ORCID:
0009-0005-2225-7346
OpenAlex ID:
A5073631412
Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer
2022
·
Akiyoshi Kasuga
, Takeshi Okamoto
, et al.
·
International Journal of Molecular Sciences
·
43
PDF
Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation
2023
·
Shohei Udagawa
, Akira Ooki
, et al.
·
Cancers
·
14
PDF
Impact of the COVID-19 Pandemic on the Management and End-of-life Care of Unresectable Pancreatic Cancer
2022
·
Akiyoshi Kasuga
, Masanori Nojima
, et al.
·
Internal Medicine
·
10
PDF
Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor
2021
·
Koichi Takeda
, Kenji Nakano
, et al.
·
Rheumatology
·
10
Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery
2025
·
Masahiro Kuno
, Hiroki Osumi
, et al.
·
Current Oncology
·
9
PDF
A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients
2022
·
Naoki Fukuda
, Kazuhisa Toda
, et al.
·
Endocrine
·
8
Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience
2025
·
Keitaro Shimozaki
, Akira Ooki
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
4
PDF
Impact of early tumor shrinkage on survival outcomes in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan in third- or later-line settings
2025
·
Koshiro Fukuda
, Hiroki Osumi
, et al.
·
Therapeutic Advances in Gastroenterology
·
4
Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma
2025
·
Mikako Tamba
, Hiroki Osumi
, et al.
·
BMC Cancer
·
4
PDF
Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy
2023
·
Shohei Udagawa
, Hiroki Osumi
, et al.
·
Surgery Today
·
4
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study
2023
·
Akihiro Ohmoto
, Kenji Nakano
, et al.
·
PLoS ONE
·
4
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer
2026
·
Koichiro Yoshino
, Manabu Takamatsu
, et al.
·
Gastric Cancer
·
3
PDF
Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023
2025
·
Keitaro Shimozaki
, Akira Ooki
, et al.
·
Therapeutic Advances in Medical Oncology
·
3
Clinicopathological characteristics and survival in metastatic colorectal cancer with short-form APC mutations.
2024
·
Hiroki Osumi
, Akira Ooki
, et al.
·
Journal of Clinical Oncology
·
3
PDF
[Delivery of a Healthy Newborn by the Partner of a Patient with CML Undergoing Treatment with Nilotinib].
2020
·
Yasuo Aota
, Shohei Udagawa
, et al.
·
PubMed
·
3
Impact of early tumor shrinkage and depth of response in patients with BRAF V600E-mutant metastatic colorectal cancer
2025
·
Shohei Udagawa
, Hiroki Osumi
, et al.
·
International Journal of Clinical Oncology
·
2
Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma that developed during myelodysplastic syndrome
2021
·
Yasuo Aota
, Susumu Maki
, et al.
·
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
·
2
PDF
Precision therapeutic strategies for advanced gastrointestinal stromal tumors
2026
·
Akira Ooki
, Hiroki Osumi
, et al.
·
Cancer and Metastasis Reviews
·
1
Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC
2025
·
Kazuo Kobayashi
, Takeru Wakatsuki
, et al.
·
Clinical and Translational Science
·
1
PDF
Effect of pretreatment vascular endothelial growth factor inhibitor use on the safety and efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer
2025
·
Koshiro Fukuda
, Hiroki Osumi
, et al.
·
International Journal of Clinical Oncology
·
1
Association of early tumor shrinkage with survival in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan.
2025
·
Koshiro Fukuda
, Akira Ooki
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Safety and tolerability of different total neoadjuvant therapy strategies in patients with locally advanced rectal cancer.
2025
·
Shohei Udagawa
, Hiroki Osumi
, et al.
·
Journal of Clinical Oncology
·
1
What is the optimal treatment strategy of salvage line treatment after progression on anti-epidermal growth factor receptor monoclonal antibody in patients with tissue RAS/BRAF wild-type metastatic colorectal cancer?
2025
·
Emiko Tange
, Hiroki Osumi
, et al.
·
Journal of Clinical Oncology
·
1
Impact of early tumor shrinkage and depth of response in patients with BRAF V600E-mutant metastatic colorectal cancer.
2024
·
Shohei Udagawa
, Hiroki Osumi
, et al.
·
Journal of Clinical Oncology
·
1
[Refractory multiple myeloma with impaired consciousness accompanied by hyperammonemia and leukoencephalopathy-like findings].
2020
·
Hikari Konuma
, Yasuo Aota
, et al.
·
PubMed
·
1
Show more works
View as search
Works count:
44
Citation count:
138
H-index:
6
I10-index:
4
Year
Topic
Type